Literature DB >> 17398004

NOx and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL.

Lijun Xu1, Bingyin Wang, Kirandeep Kaur, Melanie F Kho, John P Cooke, Rona G Giffard.   

Abstract

Both nitric oxide and asymmetric dimethylarginine (ADMA) play a critical role in the regulation of cerebral blood flow, though their neuroprotective and cytotoxic effects are still under investigation. In this study, we found that nitrate/nitrite (NOx) levels in plasma, ischemic brain tissue, and cerebrospinal fluid (CSF) increased significantly 24h after 2h transient middle cerebral artery occlusion (MCAO) in rats. ADMA levels were unchanged in plasma, but decreased significantly in CSF 24h following MCAO. The CSF ADMA/NOx ratio decreased markedly following ischemia. Rats protected by expression of the chaperonin GroEL or its folding deficient mutant D87K had lower plasma NOx levels at 24h reperfusion. ADMA, NO, and their ratio in CSF merit further study as biomarkers for ischemic brain injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17398004      PMCID: PMC2430977          DOI: 10.1016/j.neulet.2007.03.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

Review 1.  Lessons learned from nitric oxide synthase knockout animals.

Authors:  P L Huang
Journal:  Semin Perinatol       Date:  2000-02       Impact factor: 3.300

Review 2.  Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology.

Authors:  Ian B Wilkinson; Stanley S Franklin; John R Cockcroft
Journal:  Hypertension       Date:  2004-07-19       Impact factor: 10.190

3.  ADMA increases arterial stiffness and decreases cerebral blood flow in humans.

Authors:  Jan T Kielstein; Frank Donnerstag; Sandra Gasper; Jan Menne; Anousheh Kielstein; Jens Martens-Lobenhoffer; Fortunato Scalera; John P Cooke; Danilo Fliser; Stefanie M Bode-Böger
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

4.  Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.

Authors:  J H Yoo; S C Lee
Journal:  Atherosclerosis       Date:  2001-10       Impact factor: 5.162

5.  Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat.

Authors:  E Kumura; H Kosaka; T Shiga; T Yoshimine; T Hayakawa
Journal:  J Cereb Blood Flow Metab       Date:  1994-05       Impact factor: 6.200

6.  Early biomarkers of stroke.

Authors:  Mark A Reynolds; Howard J Kirchick; Jeffrey R Dahlen; Joseph M Anderberg; Paul H McPherson; Kevin K Nakamura; Daniel T Laskowitz; Gunars E Valkirs; Kenneth F Buechler
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

7.  An improved method for using cisternal cerebrospinal fluid in conscious rats for application in the measurement of catecholamines.

Authors:  Y Takemoto
Journal:  Jpn J Physiol       Date:  1991

Review 8.  Role of nitric oxide after brain ischaemia.

Authors:  M A Moro; A Cárdenas; O Hurtado; J C Leza; I Lizasoain
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

9.  Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.

Authors:  Hayan Dayoub; Vinod Achan; Shanthi Adimoolam; Johannes Jacobi; Marcus C Stuehlinger; Bing-yin Wang; Philip S Tsao; M Kimoto; Patrick Vallance; Andrew J Patterson; John P Cooke
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

10.  Does nitric oxide contribute to iron-dependent brain injury after experimental cerebral ischaemia?

Authors:  A Gámez; T Carbonell; R Rama
Journal:  J Physiol Biochem       Date:  2003-12       Impact factor: 4.158

View more
  4 in total

1.  Correlation of Serum Nitric Oxide (NO) with Glasgow Coma Scale (GCS) in Acute Ischemic Stroke Patient: A Study in North India.

Authors:  Priti Chaturvedi; Vinit Mehrotra; Yogesh Saxena; Soumen Manna
Journal:  Indian J Clin Biochem       Date:  2017-07-05

2.  Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men.

Authors:  Akihiro Nakamura; Shoko Kajitani; Kenjiro Sato; Masanori Kanazawa; Masateru Kondo; Hideaki Endo; Eiji Nozaki
Journal:  J Med Ultrason (2001)       Date:  2019-04-23       Impact factor: 1.314

3.  Association of dimethylarginines and mediators of inflammation after acute ischemic stroke.

Authors:  Shufen Chen; Jens Martens-Lobenhoffer; Karin Weissenborn; Jan T Kielstein; Ralf Lichtinghagen; Milani Deb; Na Li; Anita B Tryc; Annemarie Goldbecker; Qiang Dong; Stefanie M Bode-Böger; Hans Worthmann
Journal:  J Neuroinflammation       Date:  2012-11-17       Impact factor: 8.322

Review 4.  Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

Authors:  Shufen Chen; Na Li; Milani Deb-Chatterji; Qiang Dong; Jan T Kielstein; Karin Weissenborn; Hans Worthmann
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.